Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Saudek

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Biochemical Journal|July 1, 1993
An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IVP S Wright, V Saudek, T J Owen, et al.
European Journal of Biochemistry|April 1, 1994
Stimulation of cGMP-dependent protein kinase I alpha by a peptide from its own sequence. An investigation by enzymology, circular dichroism and 1H NMR of the activity and structure of cGMP-dependent protein kinase I alpha-(546-576)-peptide amideJ P Huggins, A J Ganzhorn, V Saudek, et al.
Journal of Molecular Biology|May 20, 1989
Identification and description of beta-structure in horse muscle acylphosphatase by nuclear magnetic resonance spectroscopyV Saudek, M R Wormald, R J Williams, et al.
European Journal of Biochemistry|August 22, 2000
Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamicsC Sich, S Improta, D J Cowley, et al.
Folia Biologica|December 12, 2007
A new mutation within the porphobilinogen deaminase gene leading to a truncated protein as a cause of acute intermittent porphyria in an extended Indian familyE Flachsová, I C Verma, D Ulbrichová, et al.
Protein Engineering|October 1, 1990
Solution structure of the DNA-binding domain of the yeast transcriptional activator protein GCN4V Saudek, A Pastore, M A Castiglione Morelli, et al.
Endocrinology|January 23, 2003
Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subjectS George, A Johansen, M A Soos, et al.
European Journal of Biochemistry|August 15, 1996
7Li nuclear-magnetic-resonance study of lithium binding to myo-inositolmonophosphataseV Saudek, P Vincendon, Q T Do, et al.
Proteins|March 28, 1998
Mapping the active site of factor Xa by selective inhibitors: an NMR and MD studyF Fraternali, Q T Do, B T Doan, et al.
Diabetes|August 13, 2014
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophyK Kozusko, Vhm Tsang, W Bottomley, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Biochemical Journal|July 1, 1993
An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IVP S Wright, V Saudek, T J Owen, et al.
European Journal of Biochemistry|April 1, 1994
Stimulation of cGMP-dependent protein kinase I alpha by a peptide from its own sequence. An investigation by enzymology, circular dichroism and 1H NMR of the activity and structure of cGMP-dependent protein kinase I alpha-(546-576)-peptide amideJ P Huggins, A J Ganzhorn, V Saudek, et al.
Journal of Molecular Biology|May 20, 1989
Identification and description of beta-structure in horse muscle acylphosphatase by nuclear magnetic resonance spectroscopyV Saudek, M R Wormald, R J Williams, et al.
European Journal of Biochemistry|August 22, 2000
Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamicsC Sich, S Improta, D J Cowley, et al.
Folia Biologica|December 12, 2007
A new mutation within the porphobilinogen deaminase gene leading to a truncated protein as a cause of acute intermittent porphyria in an extended Indian familyE Flachsová, I C Verma, D Ulbrichová, et al.
Protein Engineering|October 1, 1990
Solution structure of the DNA-binding domain of the yeast transcriptional activator protein GCN4V Saudek, A Pastore, M A Castiglione Morelli, et al.
Endocrinology|January 23, 2003
Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subjectS George, A Johansen, M A Soos, et al.
European Journal of Biochemistry|August 15, 1996
7Li nuclear-magnetic-resonance study of lithium binding to myo-inositolmonophosphataseV Saudek, P Vincendon, Q T Do, et al.
Proteins|March 28, 1998
Mapping the active site of factor Xa by selective inhibitors: an NMR and MD studyF Fraternali, Q T Do, B T Doan, et al.
Diabetes|August 13, 2014
Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophyK Kozusko, Vhm Tsang, W Bottomley, et al.
Pageof 5